Moderna gets FDA okay for RSV vaccine mResvia
Moderna has secured FDA approval for its respiratory syncytial virus (RSV) vaccine, giving it a chance to generate revenue from a second product as sales of its Spikevax C
ASCO: Novartis’ Scemblix aces first-line CML study
Novartis’ first-in-class STAMP inhibitor Scemblix could be headed for use earlier in the treatment pathway for chronic myeloid leukaemia (CML).
Novartis cues up filings for remibrutinib in chronic hives
Novartis is just months away from filing for approval of oral BTK inhibitor remibrutinib as a treatment for chronic spontaneous urticaria – also known as chronic hives – a
Dupixent nears EU approval for COPD, as FDA delays
Sanofi and Regeneron’s immunology juggernaut Dupixent is on the brink of another big new indication after it was recommended by the EMA’s human medicines committee for chr
Astellas refiles CLDN 18.2 cancer drug after FDA knockback
The US FDA has started a fresh review of Astellas' zolbetuximab, trying to become the first claudin (CLDN) 18.2-targeting drug to reach the US market, after turning it dow
Sales & Marketing
Digital
Market Access
Oncology
Patients
R&D
Partner Content
6th Macrophage-Directed Therapies Summit
Unravel Complex Macrophage Biology, Accelerate Novel Target Discovery, & Drive Clinical Proof of Concept to Deliver the Blockbuster Potential of Macrophage Therapeutics in Oncology & Beyond
3rd mRNA Process Development & Manufacturing Summit
Your Roadmap for mRNA Process Development & Manufacturing with Optimized Purification, Process Analytics & Enhanced Formulation to Improve Cost-Effectiveness & Scalability into
2nd mRNA Quality Control & Compliance Summit
The 2nd mRNA Quality Control & Compliance Summit 2024 returns this June 25-27 (Boston, MA), as the sole industry-centred forum dedicated to showcasing technical data and though
The 9th CAR-TCR Summit Returns to Boston!
The commercial success of cell therapies is continuing to grow!
Word Monster and the PM Society Join Forces to Elevate Medic...
The PM Society and Word Monster are joining forces in a new partnership focusing on raising standards and nurturing talent in the MedComms industry.